This site is intended for healthcare professionals
Anti-platelet hero
Antiplatelet therapy in ACS: Choices and Controversies

ESC 2022 Highlights

Read time: 10 mins
Last updated:22nd Sep 2022
Published:2nd Nov 2022

The latest in Acute Coronary Syndrome from ESC 2022

From the 2022 European Society of Cardiology (ESC) congress in Barcelona, receive original content on developments in acute coronary syndrome (ACS) treatments, focusing on international guideline updates, and antiplatelet therapies such as P2Y12 inhibitors.

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: